GB826362A - Steroid compounds and therapeutic compositions containing them - Google Patents

Steroid compounds and therapeutic compositions containing them

Info

Publication number
GB826362A
GB826362A GB36493/55A GB3649355A GB826362A GB 826362 A GB826362 A GB 826362A GB 36493/55 A GB36493/55 A GB 36493/55A GB 3649355 A GB3649355 A GB 3649355A GB 826362 A GB826362 A GB 826362A
Authority
GB
United Kingdom
Prior art keywords
retrocortin
hydroretrocortin
butylacetates
fluoro
hydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB36493/55A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB826362A publication Critical patent/GB826362A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises retrocortin compounds of the general formula <FORM:0826362/IV (b)/1> in which R is a keto or b -hydroxy radical, and Y is a hydrogen or halogen atom, and a process for-their preparation by reacting tertiary butyl-acetyl chloride with the corresponding retrocortin derivative possessing a free 21-hydroxy group, the reaction being effected in the presence of a base and preferably at from 0-5 DEG C. Specified products include the 21-tertiary butyl-acetates of retrocortin, hydro-retrocortin, and their 9a -fluoro- and 9a -chloro derivatives. In examples: (1) retrocortin in pyridine is treated with t-butylacetyl chloride in chloroform, the mixture poured into water and retrocortin 21-t-butylacetate isolated with chloroform and crystallized from ethanol; similarly (2) to (4) are prepared the t-butylacetates of hydro-retrocortin, its 9a -fluoro derivative, and of 9a -fluororetrocortin. Specifications 823,940, 826,361 and 826,364 are referred to.ALSO:Pharmaceutical compositions useful in the treatment of rheumatic conditions comprise suspensions of the 21-t-butylacetates of retrocortin, hydroretrocortin, or their 9a -fluoroderivatives in a suitable vehicle, particularly an aqueous carrier, which may also contain surface active agents or suspending agents and which may further contain other esters of retrocortin and related compounds in addition to the t-butylacetate ester. A specified composition contains the 21-t-butylacetates of hydroretrocortin and 9-fluoro-hydroretrocortin in an aqueous medium. Specifications 823,940, 826,361 and 826,364, [all in Group IV (b)], are referred to.
GB36493/55A 1955-01-14 1955-12-20 Steroid compounds and therapeutic compositions containing them Expired GB826362A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US826362XA 1955-01-14 1955-01-14

Publications (1)

Publication Number Publication Date
GB826362A true GB826362A (en) 1960-01-06

Family

ID=22172410

Family Applications (1)

Application Number Title Priority Date Filing Date
GB36493/55A Expired GB826362A (en) 1955-01-14 1955-12-20 Steroid compounds and therapeutic compositions containing them

Country Status (1)

Country Link
GB (1) GB826362A (en)

Similar Documents

Publication Publication Date Title
US2831003A (en) Cycloborate esters of 16alpha, 17alpha-dihydroxy steroids
US3485852A (en) 6-halo-6-dehydro-progesterones
YU35148B (en) Process for obtaining pregnane acid derivatives
GB826362A (en) Steroid compounds and therapeutic compositions containing them
US3026317A (en) [3, 2-c]-pyrimidine derivatives of androstane compounds
US3433813A (en) 1-adamantyl and 1-adamantylmethyl carbonates of testosterone and selected derivatives
US3488421A (en) Terpenic esters of glucocorticoids
FR2401934A1 (en) NEW PROCESS FOR THE PREPARATION OF OXIMES IN 3 FROM STEROID DERIVATIVES
US2985650A (en) 6alpha-ammonio-derivatives of 11-keto cortical hormones
US3030391A (en) 12-alkoxy-11-oxygenated pregnanes
US3716530A (en) Halogenation of steroids
US2908694A (en) 7-substituted thio-4-androstenes
US3816480A (en) -oxygenated 21-dialkylamino-20-methyl-5alpha-pregn-17(20)-dien-3-ones and congeners
GB1110792A (en) Novel 5(10)-dehydro-steroids
US2915434A (en) 16-fluoro-3-keto-17beta-(beta-hydroxy-propanoyl)-delta4-androstenes and derivatives thereof
US3340251A (en) 17beta-hydroxy-17alpha-halohydrocarbon-19-nor-androst-4-ene-3-ones and the delta5(10)-isomers thereof
US3810926A (en) 21-dialkylamino-20-methylpregna-4,17(20)-dien-3-ones and congeners
US3196149A (en) New 16-substituted pregnenes
US3478068A (en) 4alpha,10alpha;2beta,1&#39; - bicyclo - 5beta - methyl - 19 - nor-steroids and their preparation
US3415854A (en) Adamantoate esters of 13beta-alkylgon-4-en-3-ols
US3337537A (en) 17alpha-unsaturated-halohydrocarbon-17beta-hydroxy-19-nor-4, 9-androstadiene-3-one 17-ethers
US2813881A (en) 9alpha-halo-17alpha-methylandrostane-3, 11beta, 17beta-triol
US3018295A (en) 21-methylene steroid compounds
US2864839A (en) delta4, 7, 9(11)-pregnatriene-17alpha, 21-diol-3, 20-dione and process therefor
US3586669A (en) Orally active anti-estrogenic compounds